Inside the Clinic: Myeloproliferative Neoplasms: Current and Future Standards of Care

April 28th 2022

Experts share insight on the evolving treatment armamentarium for myeloproliferative neoplasms. 

My Treatment Approach: Metastatic Melanoma

April 26th 2022

Dr. Michael Atkins and Dr. Evan Lipson discuss the state of metastatic melanoma, contemporary and emerging treatment strategies, and break down a specific patient profile. Their conversation touches on the pros and cons of different treatment strategies for newly diagnosed patients as well as second- and third-line treatment strategies. Dr. Atkins and Dr. Lipson also take time to provide their personal experiences, preferences, and thoughts on prospects involving the treatment and management of metastatic melanoma.

My Treatment Approach: Applying Evidence to Clinical Practice to Improve Outcomes in Differentiated Thyroid Cancer

April 15th 2022

Experts in the field of differentiated thyroid cancer highlight recent advances in treatment by reviewing two real-world patient scenarios.

The Evolving Landscape of Molecular Alterations in NSCLC: Optimizing Testing and Treatment to Improve Outcomes

April 15th 2022

Expert oncologists share updates on the testing and treatment of molecular alterations in advanced non-small cell lung cancer.

The Evolving Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer

April 7th 2022

Shared insight on the evolving treatment armamentarium for metastatic CRPC and how expert physicians are optimizing care.

Improving Outcomes in Advanced RCC: Translating Evidence to Clinical Practice

April 5th 2022

A discussion on recent advances in the treatment of advanced renal cell carcinoma and their impact on clinical practice, illustrated by real-world patient profiles.

Inside the Clinic: Updates in Diagnosis, Treatment, and Management of Chronic Graft-Versus-Host Disease

April 1st 2022

Expert perspectives on historical and novel treatment strategies for patients diagnosed with chronic graft-versus-host disease.

Inside the Clinic: Optimizing Outcomes in Patients With RCC: Translating Evidence to Clinical Practice

March 21st 2022

Centering discussion on patient profiles, expert panelists review recent advances in the treatment of renal cell carcinoma and their impact on clinical practice.

Updates on First-line and Subsequent Treatment Options for Advanced Endometrial Cancer

March 15th 2022

This OncLive Insights features a medical oncologist and gynecologic oncologist who share their thoughts on the selection of first-line and subsequent therapy in advanced endometrial cancer. They discuss treatment strategies and novel therapeutics that may improve health outcomes in patients with the disease.

My Treatment Approach: Endometrial Carcinoma

March 4th 2022

Expert gynecologic oncologists provide a discussion on the care of patients with endometrial carcinoma.

Treatment Approaches in Advanced Urothelial Cancer

February 3rd 2022

Insight regarding the utilization of antibody-drug conjugate therapy to treat relapsed/refractory advanced bladder cancer.

Advances in Targeted Therapy for R/R CLL

January 28th 2022

Nicole Lamanna, MD, and Nirav N. Shah, MD, discuss the use of BTK inhibitors as targeted therapy for chronic lymphocytic leukemia and recent advancements.

Management of Patients with Immune Thrombocytopenia

January 26th 2022

This OncLive Insights features three immune thrombocytopenia experts who share their approach to treating different patient populations, considerations when selecting treatments, and emerging therapies for this condition.

Adult Relapsed Refractory B-cell Acute Lymphoblastic Leukemia: 2021 Updates

January 25th 2022

Recommendations for assessing and treating patients with relapsed/refractory B-cell ALL based on more recent data presented at ASH 2021.

The Evolving Treatment Landscape of Metastatic Urothelial Carcinoma

December 23rd 2021

Expert oncologists navigate the evolving treatment landscape of advanced or metastatic urothelial carcinoma.

BCMA-Targeting Agents in the Treatment of Multiple Myeloma: Right Patient, Right Time

December 23rd 2021

An overview of the role of currently-available and emerging BCMA-targeting therapies in the treatment landscape for multiple myeloma.

Small Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome

December 21st 2021

David Gerber, MD, and Steven Vernino, PhD, provide a discussion on Lambert-Eaton Myasthenic Syndrome (LEMS), its association with small cell lung cancer, and the available treatment options.

Advances in Treatment of Previously Treated Ph+ Chronic Myeloid Leukemia

December 14th 2021

Experts come together to share their perspective on the paradigm of previously treated Ph+ chronic myeloid leukemia.

My Treatment Approach: Chronic Lymphocytic Leukemia

December 13th 2021

Approaches to planning treatment for patients with newly diagnosed chronic lymphocytic leukemia, as recommended by healthcare professionals from Memorial Sloan Kettering Cancer Center.

Updates in the Treatment of HER2+ Metastatic Breast Cancer

December 1st 2021

Discussion of recent clinical trial updates in HER2-positive metastatic breast cancer and implications for managing 2 patient case scenarios.